[go: up one dir, main page]

FR2088019A1 - Esters of 2 and 6-substituted nicotinic acids - with vasomotor active - Google Patents

Esters of 2 and 6-substituted nicotinic acids - with vasomotor active

Info

Publication number
FR2088019A1
FR2088019A1 FR7016802A FR7016802A FR2088019A1 FR 2088019 A1 FR2088019 A1 FR 2088019A1 FR 7016802 A FR7016802 A FR 7016802A FR 7016802 A FR7016802 A FR 7016802A FR 2088019 A1 FR2088019 A1 FR 2088019A1
Authority
FR
France
Prior art keywords
active
vasomotor
esters
nicotinic acids
substituted nicotinic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7016802A
Other languages
French (fr)
Other versions
FR2088019B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RABOT ETS DAVID
Original Assignee
RABOT ETS DAVID
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RABOT ETS DAVID filed Critical RABOT ETS DAVID
Priority to FR7016802A priority Critical patent/FR2088019A1/en
Priority to GB1249771A priority patent/GB1352415A/en
Priority to ES71390924A priority patent/ES390924A1/en
Priority to BE766808A priority patent/BE766808A/en
Publication of FR2088019A1 publication Critical patent/FR2088019A1/en
Application granted granted Critical
Publication of FR2088019B1 publication Critical patent/FR2088019B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Cpds. are of formula: (where R is aliphatic, araliphatic, heteroaliphatic or aminoalkyl; R2 and R6 = opt. substd. 1-20C aliphatic gps., alkenylaromatic, alkenylheterocyclic, alklaromatic, alkylheterocyclic. Prefd. gps. R are -A.B where B is dimethylamino, diethylamino, pyrrolidino, piperidino, hexamethyleneimino, morpholino, piperazino, N-methylpiperazino; A is -CH2-CH2- or -CH2.CH2-CH2-). Cpds. have vasomotor activity, active in animals at parenteral doses of 10 mg/kg.
FR7016802A 1970-05-03 1970-05-08 Esters of 2 and 6-substituted nicotinic acids - with vasomotor active Granted FR2088019A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR7016802A FR2088019A1 (en) 1970-05-08 1970-05-08 Esters of 2 and 6-substituted nicotinic acids - with vasomotor active
GB1249771A GB1352415A (en) 1970-05-03 1971-04-30 Esters of substituted nicotine acids
ES71390924A ES390924A1 (en) 1970-05-03 1971-05-06 Esters of substituted nicotine acids
BE766808A BE766808A (en) 1970-05-03 1971-05-06 NEW ESTERS OF SUBSTITUTE NICOTINIC ACID

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7016802A FR2088019A1 (en) 1970-05-08 1970-05-08 Esters of 2 and 6-substituted nicotinic acids - with vasomotor active

Publications (2)

Publication Number Publication Date
FR2088019A1 true FR2088019A1 (en) 1972-01-07
FR2088019B1 FR2088019B1 (en) 1974-08-30

Family

ID=9055254

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7016802A Granted FR2088019A1 (en) 1970-05-03 1970-05-08 Esters of 2 and 6-substituted nicotinic acids - with vasomotor active

Country Status (1)

Country Link
FR (1) FR2088019A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2205515A1 (en) * 1972-11-08 1974-05-31 Hokuriku Pharmaceutical
US7199140B2 (en) 2001-06-26 2007-04-03 Astrazeneca Ab Vinyl phenyl derivatives as GLK activators
US7390908B2 (en) 2001-08-17 2008-06-24 Astrazeneca Ab Compounds effecting glucokinase
US7642259B2 (en) 2005-07-09 2010-01-05 Astrazeneca Ab Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
US7696191B2 (en) 2006-12-21 2010-04-13 Astrazeneca Ab Crystalline compound
US7700640B2 (en) 2004-10-16 2010-04-20 Astrazeneca Ab Process for making phenoxy benzamide compounds
US7709505B2 (en) 2002-11-19 2010-05-04 Astrazeneca Ab Benzofuran derivatives, process for their preparation and intermediates thereof
US7902200B2 (en) 2006-10-23 2011-03-08 Astrazeneca Ab Chemical compounds
US7973178B2 (en) 2005-11-28 2011-07-05 Astrazeneca Ab Chemical process for the preparation of an amido-phenoxybenzoic acid compound
US8071608B2 (en) * 2009-04-09 2011-12-06 Astrazeneca Ab Therapeutic agents

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200600086A (en) 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
TW200714597A (en) 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
SA07280576B1 (en) 2006-10-26 2011-06-22 استرازينيكا ايه بي Benzoyl amino heterocyclyl compounds as glucokinase (GLK) activators
BRPI0917589A2 (en) 2008-08-04 2015-11-17 Astrazeneca Ab compound, pharmaceutical composition, use of a compound, method for treating disease, process, pharmaceutical combination, and reaction of methyloxyran-2-carboxylate (ix) with a roh alcohol
GB0902406D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
GB0902434D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
AR076220A1 (en) 2009-04-09 2011-05-26 Astrazeneca Ab DERIVATIVES OF PIRAZOL [4,5 - E] PYRIMIDINE

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH458344A (en) * 1964-01-20 1968-06-30 Orgamol Sa Process for the preparation of basic esters of pyridine carboxylic acids
JPS644086A (en) * 1987-06-26 1989-01-09 Yokogawa Electric Corp Quantum resistance standard

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH458344A (en) * 1964-01-20 1968-06-30 Orgamol Sa Process for the preparation of basic esters of pyridine carboxylic acids
JPS644086A (en) * 1987-06-26 1989-01-09 Yokogawa Electric Corp Quantum resistance standard

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2205515A1 (en) * 1972-11-08 1974-05-31 Hokuriku Pharmaceutical
US7199140B2 (en) 2001-06-26 2007-04-03 Astrazeneca Ab Vinyl phenyl derivatives as GLK activators
US7390908B2 (en) 2001-08-17 2008-06-24 Astrazeneca Ab Compounds effecting glucokinase
US7524957B2 (en) 2001-08-17 2009-04-28 Astrazeneca Ab Compounds effecting glucokinase
US7951830B2 (en) 2001-08-17 2011-05-31 Astrazeneca Ab Compounds effecting glucokinase
US7709505B2 (en) 2002-11-19 2010-05-04 Astrazeneca Ab Benzofuran derivatives, process for their preparation and intermediates thereof
US7700640B2 (en) 2004-10-16 2010-04-20 Astrazeneca Ab Process for making phenoxy benzamide compounds
US7642259B2 (en) 2005-07-09 2010-01-05 Astrazeneca Ab Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
US7642263B2 (en) 2005-07-09 2010-01-05 Astrazeneca Ab Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
US7977328B2 (en) 2005-07-09 2011-07-12 Astrazeneca Ab Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
US7973178B2 (en) 2005-11-28 2011-07-05 Astrazeneca Ab Chemical process for the preparation of an amido-phenoxybenzoic acid compound
US7902200B2 (en) 2006-10-23 2011-03-08 Astrazeneca Ab Chemical compounds
US7696191B2 (en) 2006-12-21 2010-04-13 Astrazeneca Ab Crystalline compound
US8071608B2 (en) * 2009-04-09 2011-12-06 Astrazeneca Ab Therapeutic agents

Also Published As

Publication number Publication date
FR2088019B1 (en) 1974-08-30

Similar Documents

Publication Publication Date Title
FR2088019A1 (en) Esters of 2 and 6-substituted nicotinic acids - with vasomotor active
RO62361A (en) DEVICE FOR THE GAS SUPPLY OF FLUIDIZED BED REACTORS
CA1016414A (en) Fluidized bed furnace having fuel air supply lance and a fuel air supply lance construction
DK139323B (en) Incinerator with fluidized bed.
GB1207999A (en) Lithographic printing
GB1251282A (en)
FI52863C (en) A new process for the preparation of piperazine morphanthridine, piperazine dibenzooxines, sepine, thiazepine and diazepine derivatives.
FR2155927A1 (en) 1-phenylcyclo hexane carboxylic acid esters - with antispasmodic and anticholinergic activity
PH10188A (en) 6-(l-3-acylamidoacetamido)-penicillanic acids,their pharmaceutically acceptable salts and their medicinal uses
FR2166101A1 (en) 1,4-di (morpholino,piperidino or pyrrolidino)-7-substd - -pyrido (3,4-d)-pyridazines - as diuretics
FR2088018A1 (en) Vasodilatory, substd nicotinic acid amino ester derivs
FR2154082A5 (en) Antiarrhythmic piperazine derivs prepn - from benzhydrylpiperazine cinnamaldehyde by leuckart reactn
GB1396465A (en) 1-arylideneamino-4-2-oxo-3-phenyl-3-benzofuryl piperazines
GB1389186A (en) Chromone derivatives processes for their manufacture
FR2073427A1 (en) 4-methyl-5-ethyl-n-heterocyclic thiazoles - with antianoxic activity
FR2235687A2 (en) 1-Trimethoxy phenyl-3-carboxamido indoles - anti-inflammatories, sedatives, vasodilators, hypotensives, analgesics, anticholinergics, anti-ulcer agents etc.
ES394969A1 (en) 5-(2-amino-alkoxy-phenoxy-methyl)-3-alkyl-isoxazoles - useful as hypotensives and sedatives
USD229892S (en) Robert c
IL44174A0 (en) Biologically active piperazine derivatives,their production and their use
FR2175565A1 (en) 10-(4-alkoxy-4-alkylpiperidinoalkyl)phenothiazines - - with neuroleptic,antihistaminic,analgesic and spasmolytic activity
FR2085647A1 (en) 6-amino-2-methyl-2-heptanols - with cardiovascular analeptic analgesic and spasmolytic activity
GB1344104A (en) Cams for knitting machines
FR2068430A1 (en) 3-dialkylaminoalkoxy coumarilonitriles vasodilatory spasmolytic
ES394968A1 (en) 5-(2-amino-alkoxy-phenoxy-methyl)-3-alkyl-isoxazoles - useful as hypotensives and sedatives
GB1143709A (en)

Legal Events

Date Code Title Description
ST Notification of lapse